NEW YORK — Pfizer's acquisition of Wyeth may shake up the pharmaceutical industry, but executives contacted by SN said it would have little impact on supermarket pharmacy.
The definitive merger was reported last week. Pfizer, here, will buy Wyeth, Madison, N.J., in a cash-and-stock transaction valued at $50.19 per share, or a total of about $68 billion. Some 8,000 jobs are expected to be eliminated.
Pfizer is the nation's leading pharmaceutical manufacturer, but